Earnings call transcript: Kaynes Technology posts strong Q1 2027 growth

Kaynes Technology India’s Q1 FY2027 revenue rose 40% YoY to INR 946 crores and EBITDA increased 31% YoY to INR 147.6 crores (15.6% margin), supported by core EMS outperformance (core growth ~48–53% vs EMS market +17%) and an order book near INR 8,900 crores. However, component inflation, forex costs and higher depreciation pressured margins, while operating cash flow stayed negative at ~INR 259 crores as receivables and inventory rose—prompting a deliberate de-growth in smart metering revenue (down 12% YoY to INR 210 crores) to protect collections. Shares reacted modestly, up 0.69% to INR 3,856.3, with management guiding margin normalization over the next 2–3 quarters and expecting smart metering clarity by the Feb 2027 earnings call; OSAT/PCB commercial revenue is targeted from Q3 FY2027 with FY2027 Capex of INR 850 crores.

Analysis

Kaynes is still winning share in Indian EMS, but the market should separate growth from quality: the headline top line is being funded by working-capital intensity and capex, so near-term EPS power is less durable than the revenue print suggests. That usually limits multiple expansion versus better cash-conversion names like DIXON and, to a lesser extent, SYRMA SGS until the balance sheet inflects.

The bigger catalyst path is 1-3 months, not the day-of reaction: investors will key on whether receivables and inventory stop outrunning sales in Q2, and whether the first OSAT/PCB commercial bookings actually begin in Q3. If those slip, the current narrative shifts from "growth compounder" to "capex cycle with execution risk," which is where valuation compression tends to happen first. Conversely, any evidence that cash conversion normalizes before OSAT/PCB revenue ramps would be a strong de-risking event.

The contrarian miss is that smart-metering de-growth may be strategically correct, not a weakness: shedding a finance-heavy subscale business could improve ROIC even if reported growth slows. The flip side is that if management keeps promising a separable structure without a concrete action plan, the market will treat it as a delayed fix rather than a catalyst. Falsifiers: a clear drop in inventory days, positive operating cash flow for two quarters, or confirmed Q3 revenue contribution from OSAT/PCB; otherwise the stock remains a "show-me" story.

Key Decisions for Investors

• Short KAYNES on strength vs long DIXON for 1-3 months: cleaner cash conversion and lower execution risk should outperform if Kaynes’ working capital stays elevated; cover if Kaynes posts two straight quarters of positive operating cash flow.
• If you want event-driven upside, buy a small KAYNES call spread only after the stock pulls back and management confirms Q2 receivables flattening; the upside is tied to a cash-flow inflection, not the current quarter.
• Avoid adding to long KAYNES until the Q2/Q3 bridge shows inventory days and receivables trending down; if those metrics do not improve by the February call, treat it as a multiple-compression setup.
• Watchlist long Genus Power / HPL Electric on any credible smart-metering divestment or spin-off announcement from Kaynes; a clean separation would transfer the financing burden to a stronger utility-platform pure play.